# US Sleeping Bruxism Treatment Market > US Sleeping Bruxism Treatment Market Research Report By Type (Primary Bruxism, Secondary Bruxism), By Treatment (Dental Approaches, Medication), By Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease, Malocclusion, Sleep Paralysis), By Patient Type (Pediatric, Adult) and By End User (Hospitals & Clinics, Dental Clinics) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.48% - **2024:** $ 129.5 Million - **2025:** $ 137.89 Million - **2035:** $ 258.39 Million - **Key Players:** Procter & Gamble (US), GlaxoSmithKline (GB), Johnson & Johnson (US), Colgate-Palmolive (US), Dentsply Sirona (US), 3M (US), Kavo Kerr (US), Oral-B (US) **Report ID:** MRFR/HC/12191-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-sleeping-bruxism-treatment-market-13716 --- ## Market Summary ## **US Sleeping Bruxism Treatment Market Overview** As per MRFR analysis, the US Sleeping Bruxism Treatment Market Size was estimated at 128.77 (USD Million) in 2023. The US Sleeping Bruxism Treatment Market Industry is expected to grow from 138.65(USD Million) in 2024 to 257.62 (USD Million) by 2035. The US Sleeping Bruxism Treatment Market CAGR (growth rate) is expected to be around 5.794% during the forecast period (2025 - 2035) ### **Key US Sleeping Bruxism Treatment Market Trends Highlighted** The US Sleeping Bruxism Treatment Market is witnessing several noteworthy trends driven primarily by an increase in awareness about oral health and sleep disorders. Growing reports of bruxism among the adult population, influenced by stress and anxiety levels, have generated significant attention towards effective treatment solutions. As the American Dental Association notes, the prevalence of sleep disorders is rising, prompting healthcare professionals to focus on bruxism as a significant concern. This heightened awareness is leading to more patients seeking diagnosis and treatment options. Another key driver in this market is the advancement in dental technology and the growing adoption of custom-made dental appliances, like nightguards, which are becoming increasingly popular in managing bruxism.These custom solutions offer improved comfort and effectiveness, catering to the specific needs of patients. Moreover, the integration of telehealth services is gaining traction, allowing patients easy access to consultations and follow-ups from the comfort of their homes, thereby removing barriers to seeking treatment. Additionally, there are emerging opportunities in holistic and alternative therapies that are starting to gain attention in the US market. Patients are looking for combined treatment approaches that address both the physiological and psychological aspects of bruxism. This trend opens doors for professionals to offer comprehensive treatment plans that may include stress management techniques, cognitive behavioral therapy, and lifestyle changes. Furthermore, as research continues to evolve, the emphasis on preventive care is strengthening the overall market. Educational initiatives aimed at informing the public on the impacts of bruxism and the importance of timely intervention are becoming more prevalent. As these trends unfold, it is clear that the US [Sleeping Bruxism Treatment](../../../reports/sleeping-bruxism-treatment-market-5422) Market is adapting to meet the growing needs of the population while providing effective solutions for bruxism. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Sleeping Bruxism Treatment Market Drivers** ### **Increasing Awareness of Sleep Disorders** In the United States, there has been a significant rise in awareness regarding sleep disorders, including sleeping bruxism. The National Sleep Foundation has reported that approximately 50-70 million adults in the US suffer from some form of sleep disorder, which correlates with the growing recognition of conditions like bruxism. This awareness drives the demand for effective treatments. Moreover, initiatives by organizations such as the American Academy of Sleep Medicine (AASM) are enhancing education about sleep health, thereby promoting the growth of the US Sleeping Bruxism Treatment Market Industry.This increasing focus on sleep health is expected to create a substantial market opportunity, pushing forward treatment options for affected individuals. ### **Technological Advancements in Treatment Options** The US Sleeping Bruxism Treatment Market Industry is being bolstered by advancements in technology, particularly in the development of dental devices and therapy options. Innovations such as custom-fit mouthguards and biofeedback therapy have shown promising results in managing bruxism. According to the American Dental Association, emerging technologies in dental treatments are improving patient outcomes by enhancing comfort and efficacy. For instance, around 30% of users report significant improvement in their symptoms with the latest mouthguard designs.This technological evolution is a driving force for the market as patients increasingly seek effective and comfortable treatment options. ### **Rise in Stress and Anxiety Levels** The increase in stress and anxiety levels in the US population is another significant driver for the US Sleeping Bruxism Treatment Market. The American Psychological Association reported that over 70% of adults experience significant stress, leading to conditions such as bruxism. Stress management programs and educational campaigns being initiated by health organizations reflect an urgent need for effective treatment solutions for stress-induced bruxism. As more people recognize the link between mental health and physical conditions, there is a growing demand for treatments that address the root causes of bruxism, ultimately expanding the market for these solutions. ## **US Sleeping Bruxism Treatment Market Segment Insights** ### **Sleeping Bruxism Treatment Market Type Insights** The US Sleeping Bruxism Treatment Market showcases a comprehensive landscape, particularly evident in its diverse types focusing on Primary and Secondary Bruxism. Primary Bruxism, often categorized as sleep-related, typically occurs without an underlying medical condition, driven instead by factors like stress, anxiety, and sleep disorders. This type is significant within the market as it aligns with the rising awareness of mental health issues among the population; hence, creating a growing demand for effective treatment solutions. Conversely, Secondary Bruxism arises as a result of other medical conditions or the intake of certain medications, implying that treatment strategies may involve a multifaceted approach.The understanding and identification of these types are crucial for healthcare professionals as they tailor interventions based on individual patient needs. A trend towards personalized healthcare and holistic approaches in therapy further emphasizes the importance of distinguishing between these two types. As a significant portion of the population in the US grapples with sleep-related disorders, the potential market for effective treatments remains substantial. The ongoing integration of digital health solutions and innovative technologies also plays a pivotal role in shaping treatment modalities, catering to both primary and secondary forms of bruxism.These advancements not only enhance treatment efficacy but also improve patient compliance, reflecting the broader trends in healthcare that prioritize convenience and accessibility. Furthermore, the emphasis on dental and oral health care is transforming how bruxism is recognized and managed within the healthcare continuum, impacting both public health initiatives and private sector investments in treatment options. The substantial focus on patient education as a key driver in managing bruxism effectively legitimizes its impact on overall oral health outcomes.This demographic engagement forms an integral part of market growth dynamics as stakeholders work collaboratively to innovate and optimize treatment frameworks tailored to mitigate the ramifications of bruxism effectively. Thus, with a projected growth trajectory and evolving therapeutic solutions, the segmentation of the US Sleeping Bruxism Treatment Market around Type not only highlights critical areas for future exploration but underscores the complexity of factors influencing patient care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Sleeping Bruxism Treatment Market Treatment Insights** The US Sleeping Bruxism Treatment Market focuses on various Treatment options aimed at alleviating the issues associated with bruxism. This segment notably includes Dental Approaches, which utilize devices such as mouthguards and splints that are designed to prevent teeth grinding and jaw clenching. These dental interventions are widely sought after due to their non-invasive nature and immediate effect on protecting dental health. Medication also plays a crucial role in the Treatment segment, where pharmacological solutions are employed to manage muscle tension and reduce stress-related bruxism episodes.The combination of these Treatment methodologies is critical due to the rising awareness of dental health and the prevalence of stress-related disorders in the US population. Further market dynamics indicate an increasing inclination towards holistic approaches to treatment, with consumers actively seeking options that not only address symptoms but also promote overall well-being. The rising incidence of bruxism-related disorders highlights the importance of effective treatment solutions to mitigate their impact on quality of life, underscoring the growing demand within this segment of the market. ### **Sleeping Bruxism Treatment Market Cause Insights** The US Sleeping Bruxism Treatment Market has seen an evolving landscape focused on various causes of the condition. Obstructive Sleep Apnea, recognized as a prominent contributor to bruxism, affects millions in the US, leading to disruptions in sleep patterns and increased stress during rest periods. Gastroesophageal Reflux Disease emerges as another significant risk factor, often causing discomfort that can trigger teeth grinding as a coping mechanism. Additionally, malocclusion, which refers to misalignment of teeth, has been noted for its correlation with bruxism, as improper bites can lead to increased dental stress and grinding.Sleep paralysis, although less common, is also associated with the condition, highlighting the intricate relationship between various sleep disorders and teeth grinding behavior. Together, these factors underscore the importance of understanding the root causes of bruxism for effective treatment and management strategies. A well-rounded approach addressing these causes could present opportunities in the market for innovative treatment solutions while emphasizing the need for comprehensive patient education. Insights into the US Sleeping Bruxism Treatment Market segmentation illustrate a growing recognition of these interrelated factors, contributing to market growth and patient awareness. ### **Sleeping Bruxism Treatment Market Patient Type Insights** The US Sleeping Bruxism Treatment Market is significantly shaped by the Patient Type segment, which comprises primarily of Pediatric and Adult categories. This segmentation is crucial as it addresses the differing treatment needs and prevalence rates of bruxism across age groups. Pediatric cases often arise due to factors such as stress or dental misalignment, necessitating age-specific therapeutic approaches, while Adult cases frequently correlate with stress, anxiety, and lifestyle choices. The effective management of bruxism in both groups not only minimizes dental wear and associated health issues but also enhances overall quality of life.As awareness of sleep disorders grows in the US, parents and adults are increasingly seeking treatment options, driving market demand. Furthermore, the development of tailored treatmentssuch as behavior modification therapies for children and advanced dental appliances for adultshighlights the importance of understanding patient demographics. The US Dental and Health associations have underscored the significance of addressing these demographic needs to ensure effective management and prevention of complications related to bruxism, thus propelling the growth of the US Sleeping Bruxism Treatment Market. ### **Sleeping Bruxism Treatment Market End User Insights** The US Sleeping Bruxism Treatment Market primarily serves the End User segment comprising Hospitals and Clinics as well as Dental Clinics. Hospitals and Clinics play a crucial role in diagnosing and managing sleeping bruxism, often offering integrated care that includes various specialists who understand both dental and sleep disorders. Dental Clinics are particularly significant as they are typically the first point of contact for patients experiencing teeth grinding and related oral health issues. These establishments provide tailored treatment options, including custom mouthguards, ensuring effective management of the condition.The rising prevalence of sleep-related disorders in the US has driven the need for specialized treatment in these settings, creating increased opportunities for patient education and access to advanced treatment modalities. Growing awareness about sleep health further supports market growth, highlighting the essential contribution of these End User segments in addressing sleeping bruxism. As the demand for comprehensive treatment strategies continues to expand, hospitals and clinics, along with dental practices, are pivotal in shaping the landscape of the US Sleeping Bruxism Treatment Market. ## **US Sleeping Bruxism Treatment Market Key Players and Competitive Insights** The US Sleeping Bruxism Treatment Market is witnessing significant growth due to the increasing awareness about dental health and the associated disorders stemming from bruxism. As individuals become more cognizant of the health risks linked to teeth grinding, demand for effective treatment options is on the rise. This market largely comprises dental devices, medications, and behavioral therapies, with various stakeholders actively participating to address the needs of those suffering from bruxism. Many companies are focusing on innovative solutions to cater to the growing patient population and improve treatment outcomes. Competitive insights reveal that the market is characterized by a mix of established players and new entrants, each striving to enhance their product portfolios and expand their market presence through strategic collaborations and technological advancements. In the context of the US Sleeping Bruxism Treatment Market, Sleep Number Corporation has carved out a strong niche by promoting specialized sleep products designed to improve overall sleep quality, which is paramount for individuals suffering from bruxism. The company's strengths lie in its ability to integrate advanced technology into sleep solutions, including adjustable mattresses and sleep tracking systems that help users identify sleep issues that can exacerbate grinding behavior. With a robust distribution network across the United States, Sleep Number Corporation effectively reaches its target audience by offering customized solutions that appeal to consumers seeking relief from sleep disturbances linked to bruxism. Their commitment to innovation and quality enhances their competitive edge in this specialized market.GlaxoSmithKline, a key player in the US Sleeping Bruxism Treatment Market, has established a substantial presence through its line of oral health products that target the symptoms associated with bruxism. The company develops and markets a range of medications aimed at alleviating the discomfort caused by teeth grinding, focusing on pharmacological solutions as well as behavioral therapies. GlaxoSmithKline's strengths include a well-established research and development pipeline and strategic mergers and acquisitions that have strengthened its portfolio and market position within the US. The company aims to leverage its extensive sales and distribution networks to reach healthcare providers and consumers effectively. By continually enhancing its offerings and incorporating user feedback into product development, GlaxoSmithKline maintains a competitive edge while adapting to the evolving landscape of the bruxism treatment market in the United States. ### **Key Companies in the US Sleeping Bruxism Treatment Market Include** ## **US Sleeping Bruxism Treatment Market Industry Developments** Recent developments in the US Sleeping Bruxism Treatment Market have shown a significant focus on enhancing treatment options and the growing awareness of the condition. Sleep Number Corporation, known for its innovative sleep products, is exploring ways to integrate technology into bruxism management. GlaxoSmithKline and Eli Lilly and Company continue to invest in Research and Development for pharmacological treatments. CPAP.com has reported increased sales of various oral appliances aimed at treating bruxism, reflecting the growing demand for effective solutions. Notably, Procter and Gamble's collaborations with dental care professionals emphasize the importance of preventive measures. Moreover, in March 2023, ResMed announced a strategic partnership with Johnson and Johnson to co-develop a new line of sleep disorder treatments, including those targeting bruxism. Haleon and OralB have also been active in exploring consumer education campaigns to raise awareness. In the past two years, the US market has experienced a measurable increase in revenues, with growth projected due to rising awareness and improved treatment options. These changes reflect an evolving landscape aimed at addressing the needs of patients suffering from this common sleep-related condition. ## **US Sleeping Bruxism Treatment Market Segmentation Insights** ### **Sleeping Bruxism Treatment Market Type Outlook** ### **Sleeping Bruxism Treatment Market Treatment Outlook** ### **Sleeping Bruxism Treatment Market Cause Outlook** ### **Sleeping Bruxism Treatment Market Patient Type Outlook** ### **Sleeping Bruxism Treatment Market End User Outlook** - Hospitals & Clinics - Dental Clinics ## Market Drivers ### Increased Focus on Oral Health The growing emphasis on oral health in the US is significantly impacting the sleeping bruxism-treatment market. With rising awareness about the consequences of untreated bruxism, including dental wear and temporomandibular joint disorders, more individuals are seeking preventive and corrective treatments. The American Dental Association has reported that nearly 10% of adults suffer from bruxism, prompting dental professionals to advocate for early intervention. This focus on oral health is likely to drive the demand for custom dental appliances and other therapeutic options. Additionally, as dental insurance plans increasingly cover bruxism treatments, more patients may pursue these solutions, further propelling market growth. The sleeping bruxism-treatment market is thus positioned to benefit from this heightened awareness and proactive approach to oral health. ### Advancements in Dental Technology Technological innovations in dental care are transforming the sleeping bruxism-treatment market. The introduction of advanced diagnostic tools, such as digital imaging and sleep monitoring devices, allows for more accurate assessments of bruxism severity. Moreover, the development of custom-fitted dental guards using 3D printing technology enhances patient comfort and compliance. These advancements not only improve treatment outcomes but also encourage more patients to seek help for their bruxism issues. The market is expected to grow as these technologies become more accessible and affordable. Furthermore, the integration of telehealth services in dental care provides patients with convenient access to consultations and follow-ups, potentially increasing treatment adherence. Overall, these technological advancements are likely to play a crucial role in shaping the future of the sleeping bruxism-treatment market. ### Rising Incidence of Sleep Disorders The increasing prevalence of sleep disorders in the US is a notable driver for the sleeping bruxism-treatment market. Studies indicate that approximately 30% of adults experience sleep disturbances, which can exacerbate bruxism. As awareness of the connection between sleep quality and bruxism grows, more individuals seek treatment options. This trend is likely to boost demand for various therapeutic solutions, including dental devices and behavioral therapies. The market is projected to expand as healthcare providers recognize the need for effective interventions. Furthermore, the rising incidence of stress-related disorders, which often contribute to bruxism, adds to the urgency for effective treatment options. Consequently, the sleeping bruxism-treatment market is expected to witness significant growth as more patients are diagnosed and treated for sleep-related issues. ### Expansion of Dental Insurance Coverage The expansion of dental insurance coverage for bruxism treatments is a significant driver for the sleeping bruxism-treatment market. As insurance providers increasingly recognize bruxism as a legitimate dental concern, more patients are likely to seek treatment options. This trend is particularly relevant in the context of rising healthcare costs, where patients are more inclined to pursue covered treatments. The availability of financial support for dental appliances and therapeutic interventions can lead to higher treatment rates among affected individuals. Additionally, as more employers offer comprehensive dental plans that include bruxism treatments, the market is expected to grow. This shift in insurance coverage is likely to enhance accessibility to necessary treatments, thereby positively impacting the sleeping bruxism-treatment market. ### Growing Awareness of Stress Management The rising recognition of stress management as a critical component of overall health is influencing the sleeping bruxism-treatment market. Stress is a well-documented trigger for bruxism, and as more individuals acknowledge its impact on their well-being, there is a corresponding increase in demand for stress-reduction therapies. Techniques such as mindfulness, cognitive behavioral therapy, and relaxation exercises are gaining popularity, leading to a holistic approach to bruxism treatment. This trend may encourage healthcare providers to incorporate stress management strategies into their treatment plans, thereby expanding the range of options available to patients. As awareness of the link between stress and bruxism continues to grow, the sleeping bruxism-treatment market is likely to experience a shift towards more comprehensive treatment modalities. ## Future Outlook The [Sleeping Bruxism Treatment Market](https://www.marketresearchfuture.com/reports/sleeping-bruxism-treatment-market-5422) is projected to grow at a 6.48% CAGR from 2025 to 2035, driven by increasing awareness and innovative treatment options. **New opportunities:** - Development of customized oral appliances for enhanced comfort and effectiveness. - Expansion of telehealth services for remote bruxism consultations. - Investment in AI-driven diagnostic tools for early detection and personalized treatment. By 2035, the market is expected to achieve substantial growth, driven by innovation and increased consumer demand. ## Segment Insights ### By Type: Primary Bruxism (Largest) vs. Secondary Bruxism (Fastest-Growing) In the US sleeping bruxism-treatment market, Primary Bruxism holds the largest share, dominating the market landscape due to its more common occurrence among individuals. This segment accounts for a significant portion of treatment demand, as many patients seek solutions for the persistent grinding of teeth primarily associated with stress, anxiety, or misaligned teeth. On the other hand, Secondary Bruxism is gaining traction, attributed to underlying health conditions and medications that increase muscle activity, leading to a rapid rise in diagnosed cases compared to its counterpart. Growth trends for these segments indicate that while Primary Bruxism remains the stable foundation of the market, Secondary Bruxism is emerging as a fast-growing area driven by increasing awareness of health issues leading to this condition. As healthcare professionals become more adept at identifying and treating Secondary Bruxism, the willingness of patients to pursue treatment options is fostering a swift expansion. This dynamic is contributing to a more diverse treatment portfolio and presenting new opportunities for market players. Primary Bruxism (Dominant) vs. Secondary Bruxism (Emerging) Primary Bruxism is characterized by its prevalence, being the primary focus of treatment strategies within the US sleeping bruxism-treatment market. Typically associated with stress and anxiety, this segment benefits from well-established treatment modalities including custom dental guards and behavioral therapy options designed to alleviate symptoms. In contrast, Secondary Bruxism represents an emerging segment, increasingly recognized for its link to other health issues such as sleep apnea and certain medications. As awareness grows, this segment is seeing innovative treatment solutions being developed, making it a vital area for growth. The differentiation in treatment approaches between these two segments underscores the market's adaptability and potential for expansion driven by evolving patient needs. ### By Cause: Obstructive Sleep Apnea (Largest) vs. Gastroesophageal Reflux Disease (GERD) (Fastest-Growing) In the US sleeping bruxism-treatment market, the predominant causes include Obstructive Sleep Apnea (OSA), Gastroesophageal Reflux Disease (GERD), Malocclusion, and Sleep Paralysis. Among these, OSA holds the largest market share due to its high prevalence and the strong correlation with sleep bruxism. GERD emerges as a leading cause as well, especially given its rising awareness and growing incidences, marking it as a significant contributor to bruxism-related issues in patients. Growth trends in the segment indicate a robust increase in the diagnosis and treatment of OSA, driven by heightened awareness and advances in medical technology. Conversely, GERD is on a rapid growth trajectory as healthcare providers increasingly recognize its impact on sleep disorders. The interplay between these conditions and factors such as lifestyle changes, diet, and stress management are pivotal drivers for market dynamics within this segment. Obstructive Sleep Apnea (Dominant) vs. Gastroesophageal Reflux Disease (GERD) (Emerging) Obstructive Sleep Apnea (OSA) is a critical factor in the US sleeping bruxism-treatment market, recognized for its dominant influence due to its high occurrence in sleep clinics. Patients with OSA often experience significant disruptions in sleep, leading to increased incidence of bruxism as a physical response to stress on the body during sleep. In contrast, Gastroesophageal Reflux Disease (GERD) is emerging as a prominent segment as more research uncovers the links between acid reflux and sleep disturbances, including bruxism. This evolving understanding highlights GERD's role as an impactful emerging cause, further emphasized by a societal shift towards addressing gastrointestinal health in connection with overall wellness and sleep quality. ### By Treatment: Mouth Guard (Largest) vs. NTI-TSS Device (Fastest-Growing) In the US sleeping bruxism-treatment market, the distribution of market share among the various treatment options reveals that Mouth Guards hold the largest segment, being widely favored due to their simplistic design and effectiveness in preventing tooth wear. Other treatments such as the NTI-TSS Device and Medication categories also show significant shares, but they do not surpass the dominance of Mouth Guards, which have become the go-to option for managing bruxism effectively. Recently, the market has been witnessing growth trends driven by increasing awareness of dental health and the adverse effects of bruxism. The NTI-TSS Device, in particular, has gained traction and is recognized as the fastest-growing segment due to its clinical efficacy and user-friendliness. Additionally, growing interest in alternative therapies like botulinum toxin type A injections showcases evolving consumer preferences towards innovative solutions for treatment. Mouth Guard: Dominant vs. NTI-TSS Device: Emerging Mouth Guards remain the dominant treatment option in the US sleeping bruxism-treatment market, known for their customizability and comfort, significantly aiding in the prevention of dental damage caused by bruxism. They are frequently recommended by dental professionals and popular among users due to their accessibility and proven effectiveness. In contrast, the NTI-TSS Device is an emerging option with strong growth, primarily targeting specific muscle relaxation during sleep. Its unique design helps minimize clenching forces, making it a favored choice among patients looking for alternative methods. The rise of NTI-TSS is indicative of a broader trend towards innovative dental solutions, making the competition between traditional and novel treatments increasingly dynamic. ### By Patient Type: Adult (Largest) vs. Pediatric (Fastest-Growing) In the US sleeping bruxism-treatment market, Adults represent the largest segment, capturing a significant share due to higher prevalence rates among this demographic. Pediatric cases, although fewer, are increasingly recognized, leading to a growing market share as awareness about this condition in children rises. The balanced distribution of male and female patients within these categories further highlights the diverse target audience for treatment options. Growth trends indicate a rising demand for tailored solutions targeting both Adult and Pediatric patients. Factors driving this growth include increasing stress levels leading to bruxism, along with heightened awareness and diagnosis rates in clinical settings. Moreover, innovative treatment solutions and preventive measures are giving parents and adults more options, consequently fueling market expansion in both segments. Adult (Dominant) vs. Pediatric (Emerging) The Adult segment is characterized by a higher occurrence of bruxism, driven by lifestyle factors such as stress and anxiety, making it the dominant patient type within the market. Treatments are often focused on custom dental solutions and stress management techniques. Conversely, the Pediatric segment, although smaller, represents an emerging space due to increased awareness and a growing understanding of bruxism in children. Parents are becoming more proactive in seeking treatment for their children, prompting manufacturers to develop specialized pediatric devices. As a result, while Adults maintain market dominance, the Pediatric segment is expected to witness significant growth in the coming years. ### By End User: Dental Clinics (Largest) vs. Hospitals & Clinics (Fastest-Growing) In the US sleeping bruxism-treatment market, the distribution of market share reveals that dental clinics hold a substantial share. They are preferred by many patients due to specialized services and tailored treatments that focus on dental health. Meanwhile, hospitals and clinics, while important, have a smaller share in comparison, as patients often seek dental clinics specifically for bruxism-related issues, leading to a clear dominance in market preference. However, hospitals and clinics are witnessing rapid growth in this segment driven by an increasing awareness of sleep disorders and the need for comprehensive treatment approaches. As healthcare providers expand their services to include dental care for bruxism, this sector is becoming the fastest-growing. Enhanced collaboration between dental professionals and hospitals is also contributing to this uptrend, addressing a broader patient demographic. Dental Clinics (Dominant) vs. Hospitals & Clinics (Emerging) Dental clinics are the dominant players in the US sleeping bruxism-treatment market due to their specialized focus on dental health and bruxism management. They provide customized treatment plans, including the use of splints and dental appliances, which directly target the condition. Patients are often more comfortable seeking treatment in these specialized settings, contributing to their larger market share. Conversely, hospitals and clinics are emerging players as they begin to recognize the importance of integrating dental care within their services. Their ability to offer a comprehensive approach, including medical evaluations and treatments, positions them for significant growth in the future as they adapt to the rising demand for holistic care. ## Competitive Benchmarking The sleeping bruxism-treatment market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Procter & Gamble (US), Johnson & Johnson (US), and Colgate-Palmolive (US) are actively pursuing strategies that emphasize product development and market expansion. Procter & Gamble (US) has focused on enhancing its product portfolio through research and development, aiming to introduce advanced oral care solutions that address bruxism effectively. Meanwhile, Johnson & Johnson (US) appears to be leveraging its extensive distribution network to penetrate new markets, thereby increasing its market share. Colgate-Palmolive (US) is also investing in digital transformation initiatives, which may enhance customer engagement and streamline operations, collectively shaping a competitive environment that prioritizes innovation and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure is moderately fragmented, with several players vying for dominance. This fragmentation allows for a diverse range of products and solutions, but it also intensifies competition among key players, who must continuously innovate to maintain their market positions. In October Procter & Gamble (US) announced a partnership with a leading dental technology firm to develop a smart mouthguard that monitors bruxism activity. This strategic move is significant as it not only positions Procter & Gamble (US) at the forefront of technological innovation but also addresses the growing consumer demand for personalized health solutions. The integration of technology into traditional oral care products could redefine consumer expectations and enhance brand loyalty. In September Johnson & Johnson (US) launched a new line of bruxism-related oral care products that incorporate natural ingredients aimed at reducing stress and anxiety, which are often linked to bruxism. This initiative reflects a broader trend towards holistic health solutions and may attract health-conscious consumers seeking alternative treatments. By diversifying its product offerings, Johnson & Johnson (US) is likely to strengthen its competitive position in the market. In August Colgate-Palmolive (US) unveiled a digital platform that provides consumers with personalized recommendations for bruxism treatment based on their specific needs. This platform not only enhances customer engagement but also positions Colgate-Palmolive (US) as a leader in digital health solutions. The strategic importance of this move lies in its potential to create a more tailored consumer experience, thereby fostering brand loyalty and increasing market penetration. As of November current trends in the sleeping bruxism-treatment market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances among companies are increasingly shaping the competitive landscape, allowing for shared resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This evolution may redefine market dynamics, compelling companies to prioritize unique value propositions that resonate with consumers. ## Recent News & Developments Recent developments in the US Sleeping Bruxism Treatment Market have shown a significant focus on enhancing treatment options and the growing awareness of the condition. Sleep Number Corporation, known for its innovative sleep products, is exploring ways to integrate technology into bruxism management. GlaxoSmithKline and Eli Lilly and Company continue to invest in Research and Development for pharmacological treatments. CPAP.com has reported increased sales of various oral appliances aimed at treating bruxism, reflecting the growing demand for effective solutions. Notably, Procter and Gamble's collaborations with dental care professionals emphasize the importance of preventive measures. Moreover, in March 2023, ResMed announced a strategic partnership with Johnson and Johnson to co-develop a new line of sleep disorder treatments, including those targeting bruxism. Haleon and OralB have also been active in exploring consumer education campaigns to raise awareness. In the past two years, the US market has experienced a measurable increase in revenues, with growth projected due to rising awareness and improved treatment options. These changes reflect an evolving landscape aimed at addressing the needs of patients suffering from this common sleep-related condition. ## Report Scope | MARKET SIZE 2024 | 129.5(USD Million) | | --- | --- | | MARKET SIZE 2025 | 137.89(USD Million) | | MARKET SIZE 2035 | 258.39(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.48% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Procter & Gamble (US), GlaxoSmithKline (GB), Johnson & Johnson (US), Colgate-Palmolive (US), Dentsply Sirona (US), 3M (US), Kavo Kerr (US), Oral-B (US) | | Segments Covered | Type, Cause, Treatment, Patient Type, End User | | Key Market Opportunities | Integration of innovative oral devices and digital health solutions enhances treatment options in the sleeping bruxism-treatment market. | | Key Market Dynamics | Rising consumer awareness drives demand for innovative treatments in the sleeping bruxism-treatment market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US sleeping bruxism-treatment market in 2024?** A: The market valuation was $129.5 Million in 2024. **Q: What is the projected market valuation for the US sleeping bruxism-treatment market by 2035?** A: The projected valuation for 2035 is $258.39 Million. **Q: What is the expected CAGR for the US sleeping bruxism-treatment market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.48% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the US sleeping bruxism-treatment market?** A: Key players include Procter & Gamble, GlaxoSmithKline, Johnson & Johnson, Colgate-Palmolive, Dentsply Sirona, 3M, Kavo Kerr, and Oral-B. **Q: What are the primary and secondary bruxism market segments valued at in 2024?** A: Primary bruxism was valued at $51.8 Million, while secondary bruxism was valued at $77.7 Million in 2024. **Q: What are the leading causes of bruxism and their market valuations in 2024?** A: Obstructive Sleep Apnea was valued at $25.0 Million, GERD at $20.0 Million, Malocclusion at $30.0 Million, and Sleep Paralysis at $54.5 Million. **Q: What treatment options are available for bruxism and their respective market valuations?** A: Mouth Guards were valued at $30.0 Million, Dental Approaches at $20.0 Million, and Medication at $15.0 Million in 2024. **Q: How does the market for pediatric and adult bruxism treatment compare in 2024?** A: Pediatric treatment was valued at $15.0 Million, whereas adult treatment was significantly higher at $70.0 Million. **Q: What is the market valuation for dental clinics in the US sleeping bruxism-treatment market?** A: The market valuation for dental clinics was $77.7 Million in 2024. **Q: What trends are expected in the US sleeping bruxism-treatment market by 2035?** A: The market is expected to grow, reaching $258.39 Million by 2035, indicating a robust demand for treatment options. **Q: What will be the projected market value of the US Sleeping Bruxism Treatment Market by 2035?** A: By 2035, the market is projected to reach 286.0 million USD. **Q: What is the expected compound annual growth rate (CAGR) for the US Sleeping Bruxism Treatment Market from 2025 to 2035?** A: The market is expected to grow at a CAGR of 6.955% from 2025 to 2035. **Q: Which type of bruxism holds a larger market share in 2024?** A: Primary Bruxism holds a larger market share valued at 80.0 million USD in 2024. **Q: What is the projected market size for Secondary Bruxism by 2035?** A: The market size for Secondary Bruxism is projected to be 116.0 million USD by 2035. **Q: What market opportunities exist in the US Sleeping Bruxism Treatment Market?** A: Emerging trends in dental technology and increasing awareness provide growth opportunities in the market. **Q: What challenges does the US Sleeping Bruxism Treatment Market face?** A: The market faces challenges such as varying diagnosis rates and treatment adherence among patients. **Q: What is the trend regarding market growth rate for Primary Bruxism from 2024 to 2035?** A: The market for Primary Bruxism is expected to grow significantly, from 80.0 million USD in 2024 to 170.0 million USD by 2035. **Q: How does the current global scenario impact the US Sleeping Bruxism Treatment Market?** A: The ongoing global scenario influences supply chain stability in the US Sleeping Bruxism Treatment Market. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-sleeping-bruxism-treatment-market-13716*